​

Funding Round

Series B - Synapse Medicine

Series B - Synapse Medicine

Investment Firm

Overview

Synapse Medicine provides medication decision solutions to deliver enhanced patient-centered insights for care teams.

Announced Date

Mar 01, 2022

Funding Type

Series B

Highlights

Location

Europe

Social

Investor Lead

Korelya Capital

Korelya Capital

Korelya Capital is a early_stage_venture and late_stage_venture and venture firm.

Participant Investors

5

Investor Name
Participant InvestorMutuelles Impact
Participant InvestorBNP Paribas Développement
Participant InvestorMACSF
Participant InvestorKorelya Capital
Participant InvestorXAnge

Round Details and Background

Synapse Medicine raised $27830501 on 2022-03-01 in Series B

Synapse Medicine provides medication decision solutions to deliver enhanced patient-centered insights for care teams.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 19, 2019
Seed Round - Synapse Medicine
1-2.8M
Jul 06, 2020
Series A - Synapse Medicine
5-8.0M
Mar 01, 2022
Series B - Synapse Medicine
5-27.8M

Recent Activity

There is no recent news or activity for this profile.